-
Je něco špatně v tomto záznamu ?
Phospholipid biosynthesis disruption renders the yeast cells sensitive to antifungals
D. Kundu, S. Hameed, Z. Fatima, R. Pasrija,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
F.No. 42-647(2013) SR
University Grants Commission
BT/PR4329/INF'22/1444/2011
Department of Biotechnology , Ministry of Science and Technology
SERB/F/4213/2013-14
Science and Engineering Research Board
- MeSH
- ABC transportéry genetika MeSH
- antifungální látky farmakologie MeSH
- biosyntetické dráhy MeSH
- Candida albicans účinky léků genetika MeSH
- delece genu MeSH
- fosfatidylethanolamin-N-methyltransferasa genetika MeSH
- fosfolipidy biosyntéza MeSH
- fungální proteiny genetika MeSH
- karboxylyasy genetika MeSH
- membránové transportní proteiny genetika MeSH
- mikrobiální testy citlivosti MeSH
- mitochondriální proteiny genetika MeSH
- mnohočetná fungální léková rezistence genetika MeSH
- Saccharomyces cerevisiae - proteiny genetika MeSH
- Saccharomyces cerevisiae genetika metabolismus MeSH
- Publikační typ
- časopisecké články MeSH
To understand the role of phospholipids on Cdr1p (drug exporter)-mediated drug resistance in yeast, the phospholipids biosynthesis genes PSD1, PSD2, CHO2, and OPI3 were deleted in a strain of Saccharomyces cerevisiae already overexpressing Cdr1-GFP of Candida albicans as a heterologous system. The effect of phospholipids biosynthesis gene deletion was analyzed on Cdr1p-GFP-mediated drug resistance as well as its localization. The results indicate that phospholipids biosynthesis disruption makes the cell sensitive to several drugs including fluconazole (FLC), with Δpsd1/Cdr1-GFP being worst affected. Interestingly, unlike sterols and sphingolipids, the localization of Cdr1p was unaffected by phospholipid biosynthesis gene disruption. Concomitantly, phospholipids mutants also showed an increase in reactive oxygen species (ROS) generation, as verified by fluorescence probe 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) method. In addition, the sensitivity of phospholipid mutants with FLC was found to be synergistic to ROS generation, resulting in further reduction of growth. Thus, this study proposes phospholipid biosynthesis as a novel target for antifungal therapy.
Amity Institute of Biotechnology Amity University Gurugram Haryana India
Department of Biochemistry Maharshi Dayanand University Rohtak Haryana India
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20024243
- 003
- CZ-PrNML
- 005
- 20201208102221.0
- 007
- ta
- 008
- 201208s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-019-00713-3 $2 doi
- 035 __
- $a (PubMed)31093957
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kundu, Deepika $u Department of Biochemistry, Maharshi Dayanand University, Rohtak, Haryana, India.
- 245 10
- $a Phospholipid biosynthesis disruption renders the yeast cells sensitive to antifungals / $c D. Kundu, S. Hameed, Z. Fatima, R. Pasrija,
- 520 9_
- $a To understand the role of phospholipids on Cdr1p (drug exporter)-mediated drug resistance in yeast, the phospholipids biosynthesis genes PSD1, PSD2, CHO2, and OPI3 were deleted in a strain of Saccharomyces cerevisiae already overexpressing Cdr1-GFP of Candida albicans as a heterologous system. The effect of phospholipids biosynthesis gene deletion was analyzed on Cdr1p-GFP-mediated drug resistance as well as its localization. The results indicate that phospholipids biosynthesis disruption makes the cell sensitive to several drugs including fluconazole (FLC), with Δpsd1/Cdr1-GFP being worst affected. Interestingly, unlike sterols and sphingolipids, the localization of Cdr1p was unaffected by phospholipid biosynthesis gene disruption. Concomitantly, phospholipids mutants also showed an increase in reactive oxygen species (ROS) generation, as verified by fluorescence probe 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) method. In addition, the sensitivity of phospholipid mutants with FLC was found to be synergistic to ROS generation, resulting in further reduction of growth. Thus, this study proposes phospholipid biosynthesis as a novel target for antifungal therapy.
- 650 _2
- $a ABC transportéry $x genetika $7 D018528
- 650 _2
- $a antifungální látky $x farmakologie $7 D000935
- 650 _2
- $a biosyntetické dráhy $7 D053898
- 650 _2
- $a Candida albicans $x účinky léků $x genetika $7 D002176
- 650 _2
- $a karboxylyasy $x genetika $7 D002262
- 650 _2
- $a mnohočetná fungální léková rezistence $x genetika $7 D026141
- 650 _2
- $a fungální proteiny $x genetika $7 D005656
- 650 _2
- $a delece genu $7 D017353
- 650 _2
- $a membránové transportní proteiny $x genetika $7 D026901
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a mitochondriální proteiny $x genetika $7 D024101
- 650 _2
- $a fosfatidylethanolamin-N-methyltransferasa $x genetika $7 D050918
- 650 _2
- $a fosfolipidy $x biosyntéza $7 D010743
- 650 _2
- $a Saccharomyces cerevisiae $x genetika $x metabolismus $7 D012441
- 650 _2
- $a Saccharomyces cerevisiae - proteiny $x genetika $7 D029701
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hameed, Saif $u Amity Institute of Biotechnology, Amity University, Gurugram (Manesar), Haryana, India.
- 700 1_
- $a Fatima, Zeeshan $u Amity Institute of Biotechnology, Amity University, Gurugram (Manesar), Haryana, India.
- 700 1_
- $a Pasrija, Ritu $u Department of Biochemistry, Maharshi Dayanand University, Rohtak, Haryana, India. ritupasrija@yahoo.com.
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 65, č. 1 (2020), s. 121-131
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31093957 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20201208 $b ABA008
- 991 __
- $a 20201208102217 $b ABA008
- 999 __
- $a ok $b bmc $g 1593198 $s 1114924
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 65 $c 1 $d 121-131 $e 20190515 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- GRA __
- $a F.No. 42-647(2013) SR $p University Grants Commission
- GRA __
- $a BT/PR4329/INF'22/1444/2011 $p Department of Biotechnology , Ministry of Science and Technology
- GRA __
- $a SERB/F/4213/2013-14 $p Science and Engineering Research Board
- LZP __
- $a Pubmed-20201208